The majority of U.S. stock indices ended lower on Nov. 12, as rising U.S. treasury yields posed a headwind to the equities’ ...
Plus: How AI can make it easier to find drugs from nature and a study suggests Ozempic could treat alcoholism.
MedPage Today on MSN17h
Targeted Combination Shows Promise in Metastatic Kidney CancerLOUISVILLE, Ky. -- More than half of patients with newly diagnosed metastatic kidney cancer responded to a novel drug ...
Midtown-based drug discovery company Schrodinger has entered a deal to advance multiple projects with pharmaceutical giant ...
Novartis (NVS) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall ...
Johnson & Johnson seeks to charge 340B-enrolled disproportionate share hospitals full price for Xarelto and Stelara and issue ...
In a report released yesterday, Evan Seigerman from BMO Capital maintained a Buy rating on Schrodinger (SDGR – Research Report), with a ...
An analyst note raising questions about Amgen’s MariTide triggered a stock sell-off Tuesday. Elsewhere, Roche and Novartis ...
The global neuroendocrine carcinoma treatment market is poised for substantial growth, with revenue expected to reach USD ...
Purpose-led collaboration is not just a buzzword; it is a strategic approach where all stakeholders come together with a ...
Gabriele Ricci, chief data and technology officer, has been reorganizing the technology function at Takeda Pharmaceutical.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback